The large-scale peptide synthesis project adopts internationally advanced technology and has established a specialized production base for domestic and international markets. The project mainly includes a peptide synthesis raw material production line and two freeze-dried powder injection production lines, with an annual production capacity of up to 5 kilograms of peptide synthesis raw materials and 5 million peptide freeze-dried powder injection preparations.
In addition, the project also involves the research and development of long-acting sustained-release microsphere formulations, using microfluidic technology to ensure uniform microsphere size, controllable particle size, and stable drug release characteristics. The application of microfluidic technology not only improves the stability and effectiveness of drug release, but also expands its applications in medical beauty filling materials and other fields.
In summary, large-scale peptide synthesis not only improves production capacity, but also enhances product diversity and market competitiveness through technological innovation.